The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern U.S.

被引:0
|
作者
Olivia T. Van Gerwen
Ibrahim Yigit
Kaylee B. Crockett
Bulent Turan
机构
[1] University of Alabama at Birmingham,Division of Infectious Diseases
[2] TED University,Department of Psychology, Faculty of Arts and Sciences
[3] University of Alabama at Birmingham,Department of Family and Community Medicine
[4] Koc University,Department of Psychology, College of Social Sciences and Humanities
[5] University of Alabama at Birmingham,Department of Psychology
来源
AIDS and Behavior | 2023年 / 27卷
关键词
HIV pre-exposure prophylaxis; Adherence; Stigma; PrEP;
D O I
暂无
中图分类号
学科分类号
摘要
Despite efficacy in HIV prevention, Pre-exposure Prophylaxis (PrEP) is underutilized in the US, especially among populations at highest risk. PrEP-related stigma may play a role. We developed measures of PrEP-related stigma dimensions and PrEP adherence. We administered them to current PrEP users. We hypothesized that PrEP-related stigma would negatively impact PrEP adherence. Questionnaire measures were developed using data from previous qualitative work and existing validated HIV-related stigma measures. The resultant survey was administered to current PrEP users from two Birmingham, Alabama PrEP clinics. Plasma tenofovir disoproxil fumarate levels were collected to measure PrEP adherence. Exploratory factor analyses were performed to determine the factor structure of each PrEP-related stigma dimension (internalized, perceived, experienced, anticipated, disclosure concerns). Separate binary logistic (or linear) regressions were performed to assess associations between PrEP-related stigma dimensions and adherence (treatment adherence self-efficacy, self-reported adherence, and plasma tenofovir levels), adjusting for education, race, and time on PrEP. In 2018, 100 participants completed the survey, with 91 identifying as male and 66 as white. Only internalized stigma was associated with lower self-reported PrEP adherence. Exploratory mediation analyses suggested that the association between all stigma dimensions and self-reported PrEP adherence is mediated by PrEP adherence self-efficacy. No associations were found between any PrEP-related stigma measures and plasma tenofovir levels. Internalized PrEP stigma may reduce PrEP adherence, possibly by reducing PrEP adherence self-efficacy among experienced PrEP users. Further investigation of how stigma dimensions affect PrEP adherence in populations at risk for HIV may shed light on drivers of PrEP underutilization.
引用
收藏
页码:1478 / 1485
页数:7
相关论文
共 50 条
  • [21] Modeling HIV Pre-Exposure Prophylaxis
    Straubinger, Thomas
    Kay, Katherine
    Bies, Robert
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [22] HIV pre-exposure prophylaxis for women
    Sheth, Anandi N.
    Rolle, Charlotte P.
    Gandhi, Monica
    [J]. JOURNAL OF VIRUS ERADICATION, 2016, 2 (03) : 149 - 155
  • [23] PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION
    Cremin, I.
    Hallett, T.
    Dybul, M.
    Piot, P.
    Garnett, G.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A36 - A36
  • [24] Pre-exposure prophylaxis against HIV
    不详
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2020, 98 (02) : 82 - 82
  • [25] Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users
    Stein, Michael
    Thurmond, Portia
    Bailey, Genie
    [J]. AIDS AND BEHAVIOR, 2014, 18 (09) : 1694 - 1700
  • [26] Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users
    Michael Stein
    Portia Thurmond
    Genie Bailey
    [J]. AIDS and Behavior, 2014, 18 : 1694 - 1700
  • [27] Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care
    Kenison, Tiffany Cho
    Badenhop, Brittan
    Safo, Stella
    [J]. AIDS PATIENT CARE AND STDS, 2020, 34 (06) : 251 - 258
  • [28] Users' expectations of the new pre-exposure prophylaxis for the HIV modalities
    de Jesus, Monica Lima
    Vargas, Maricelly Gomez
    Iniguez-Rueda, Lupicinio
    Fernandez-Gonzalez, Emmanuelle
    da Silva, Luis Augusto Vasconcelos
    Cabrera, Jose Miguel
    Perez, Felix
    Saz, Jorge
    [J]. CIENCIA & SAUDE COLETIVA, 2024, 29 (06):
  • [29] Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
    Montgomery, Madeline C.
    Oldenburg, Catherine E.
    Nunn, Amy S.
    Mena, Leandro
    Anderson, Peter
    Liegler, Teri
    Mayer, Kenneth H.
    Patel, Rupa
    Almonte, Alexi
    Chan, Philip A.
    [J]. PLOS ONE, 2016, 11 (06):
  • [30] Reported Side Effects and Adherence of Daily HIV Pre-Exposure Prophylaxis Users in Ontario, Canada: An Analysis of the Ontario Pre-Exposure Prophylaxis Cohort Study
    Rudd, Monica
    McGarrity, Matthew
    Lisk, Ryan
    MacPherson, Paul
    Knox, David
    Woodward, Kevin
    Reinhart, Jeff
    MacLeod, John
    Bogoch, Isaac I.
    Clatworthy, Deanna
    Biondi, Mia J.
    Sullivan, Sean
    Li, Alan
    Durrant, Garfield
    Schonbe, Andrew
    Ongoiba, Fanta
    Burchell, Ann N.
    Tan, Darrell H. S.
    [J]. AIDS PATIENT CARE AND STDS, 2024, 38 (09) : 382 - 392